This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (4)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

ERIC L. SMITH, M.D.

AMA Arch Ophthalmol. 1953;49(3):303-312.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE INTRAVENOUS use of corticotropin (ACTH) in the treatment of optic neuritis merits serious consideration. It is my purpose in this paper to review the current literature on the subject and to illustrate the use of the drug by reporting my experience in the successful treatment of a patient with intravenous administration of corticotropin. The case presented itself shortly after publication of the recent article by Gordon and associates¹ on their experiences with corticotropin and cortisone therapy in acute ocular conditions, in which they stated that "intravenous drip ACTH is the most effective weapon available today," and after Dr. Allan Wood's report at a meeting of the New York Academy of Medicine, Section of Ophthalmology, on the effectiveness of the intravenous use of corticotropin. Current literature on the use of corticotropin in all fields of medicine is voluminous, but relatively few articles are concerned with its intravenous use.² . . . [Full Text PDF of this Article]

Author Affiliations
NEW YORK

Footnotes
Resident in Ophthalmology at Manhattan Eye, Ear and Throat Hospital.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?